AI Engines For more Details: Perplexity Kagi Labs You
Antioxidant activity: Rosmarinic acid exhibits strong antioxidant properties, helping to neutralize harmful free radicals in the body. By reducing oxidative stress and preventing cellular damage, rosmarinic acid may help protect against chronic diseases such as heart disease, cancer, diabetes, and neurodegenerative disorders.
Anti-inflammatory effects: Rosmarinic acid has been shown to inhibit inflammatory pathways in the body, reducing the production of pro-inflammatory molecules such as cytokines and prostaglandins. This anti-inflammatory activity may help alleviate symptoms of inflammatory conditions such as arthritis, asthma, inflammatory bowel disease (IBD), and skin inflammation.
Allergy relief: Rosmarinic acid has been studied for its potential to alleviate allergy symptoms by inhibiting the release of histamine and other inflammatory mediators. It may help reduce nasal congestion, sneezing, itching, and other symptoms associated with allergic rhinitis, allergic asthma, and other allergic conditions.
Neuroprotective effects: Rosmarinic acid has shown promise in protecting brain cells from oxidative stress and inflammation, which are implicated in neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease. It may help prevent or slow down the progression of these diseases by preserving neuronal function and reducing neuroinflammation.
Gastrointestinal health: Rosmarinic acid has been investigated for its potential benefits for digestive health. It may help protect the gastrointestinal mucosa from damage caused by inflammation, infection, or oxidative stress. Additionally, rosmarinic acid may have antimicrobial properties that help inhibit the growth of harmful bacteria in the gut.
Skin conditions: Topical application of rosmarinic acid or extracts containing rosmarinic acid may help alleviate symptoms of various skin conditions, including acne, eczema, and dermatitis. It has anti-inflammatory and antimicrobial properties that can help reduce redness, swelling, and bacterial overgrowth on the skin.
Cardiovascular health: Rosmarinic acid may have cardiovascular benefits due to its antioxidant and anti-inflammatory properties. It may help improve blood vessel function, reduce blood pressure, lower cholesterol levels, and prevent the formation of blood clots, thereby reducing the risk of heart disease and stroke.
Antimicrobial activity: Rosmarinic acid exhibits antimicrobial properties against a wide range of bacteria, viruses, fungi, and parasites. It may help inhibit the growth of pathogens and prevent infections, making it a potential therapeutic agent for infectious diseases.
| Rank | Probiotic | Impact |
|---|---|---|
| species | Escherichia coli | Reduces |
| species | Lactobacillus johnsonii | Increases |
| strain | Escherichia coli G3/10 | Reduces |
| strain | Escherichia coli Nissle 1917 | Reduces |
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
| Condition | Positive Impact | Negative Impact | Benefit Ratio Impact |
|---|---|---|---|
| Acne | 0.3 | 0.3 | 0 |
| ADHD | 0.6 | 0.6 | |
| Allergic Rhinitis (Hay Fever) | 0.6 | 0.3 | 1 |
| Allergies | 0.8 | 0.8 | |
| Allergy to milk products | 0.5 | 0.5 | 0 |
| Alzheimer's disease | 0.8 | 0.5 | 0.6 |
| Amyotrophic lateral sclerosis (ALS) Motor Neuron | 0.5 | 0.8 | -0.6 |
| Ankylosing spondylitis | 1.3 | 1.3 | |
| Antiphospholipid syndrome (APS) | 0.5 | 0.5 | |
| Asthma | 0.3 | 0.3 | |
| Atherosclerosis | 0.3 | 0.3 | 0 |
| Atrial fibrillation | 0.3 | 0.8 | -1.67 |
| Autism | 1.3 | 0.8 | 0.63 |
| benign prostatic hyperplasia | 0.3 | 0.3 | |
| Bipolar Disorder | 0.3 | 0.3 | |
| Brain Trauma | 0.6 | 0.6 | |
| Breast Cancer | 0.3 | -0.3 | |
| Carcinoma | 0.5 | 0.3 | 0.67 |
| Celiac Disease | 0.5 | 0.6 | -0.2 |
| Cerebral Palsy | 0.3 | 0.3 | |
| Chronic Fatigue Syndrome | 0.6 | 0.3 | 1 |
| Chronic Kidney Disease | 0.6 | 0.3 | 1 |
| Chronic Obstructive Pulmonary Disease (COPD) | 0.3 | 0.3 | |
| Chronic Urticaria (Hives) | 0.8 | 0.8 | |
| Coagulation / Micro clot triggering bacteria | 0.8 | 0.8 | |
| Colorectal Cancer | 1 | 0.3 | 2.33 |
| Constipation | 0.3 | 0.3 | |
| COVID-19 | 1.6 | 0.8 | 1 |
| Crohn's Disease | 1.8 | 0.8 | 1.25 |
| cystic fibrosis | 0.8 | 0.3 | 1.67 |
| deep vein thrombosis | 0.8 | 0.8 | |
| Depression | 1.3 | 0.8 | 0.63 |
| Dermatomyositis | 0.3 | -0.3 | |
| Eczema | 0.5 | 0.3 | 0.67 |
| Endometriosis | 1.3 | 1.3 | |
| Epilepsy | 0.8 | 0.3 | 1.67 |
| Fibromyalgia | 0.3 | 0.3 | 0 |
| Functional constipation / chronic idiopathic constipation | 1.3 | 0.3 | 3.33 |
| gallstone disease (gsd) | 0.8 | 0.3 | 1.67 |
| Generalized anxiety disorder | 0.8 | 0.3 | 1.67 |
| Graves' disease | 0.3 | 0.3 | 0 |
| Hashimoto's thyroiditis | 0.5 | 0.3 | 0.67 |
| Histamine Issues,Mast Cell Issue, DAO Insufficiency | 0.5 | 0.5 | |
| hyperglycemia | 0.6 | 0.3 | 1 |
| Hyperlipidemia (High Blood Fats) | 0.6 | 0.6 | |
| hypertension (High Blood Pressure | 0.8 | 0.6 | 0.33 |
| Hypothyroidism | 0.3 | -0.3 | |
| Hypoxia | 0.3 | -0.3 | |
| IgA nephropathy (IgAN) | 0.3 | 0.3 | 0 |
| Inflammatory Bowel Disease | 1.3 | 0.6 | 1.17 |
| Insomnia | 0.3 | -0.3 | |
| Intracranial aneurysms | 0.3 | 0.3 | |
| Irritable Bowel Syndrome | 1.3 | 0.6 | 1.17 |
| Liver Cirrhosis | 0.8 | 0.6 | 0.33 |
| Long COVID | 1.1 | 0.8 | 0.38 |
| Lung Cancer | 0.3 | 0.3 | |
| ME/CFS with IBS | 0.3 | -0.3 | |
| ME/CFS without IBS | 0.3 | -0.3 | |
| Metabolic Syndrome | 1.8 | 1.3 | 0.38 |
| Mood Disorders | 1.6 | 1.1 | 0.45 |
| multiple chemical sensitivity [MCS] | 0.3 | -0.3 | |
| Multiple Sclerosis | 0.6 | 0.3 | 1 |
| Multiple system atrophy (MSA) | 0.6 | -0.6 | |
| Neuropathy (all types) | 0.6 | -0.6 | |
| neuropsychiatric disorders (PANDAS, PANS) | 0.5 | 0.5 | |
| Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic | 0.3 | 0.3 | 0 |
| NonCeliac Gluten Sensitivity | 0.3 | -0.3 | |
| Obesity | 0.8 | 0.6 | 0.33 |
| obsessive-compulsive disorder | 1.1 | 0.5 | 1.2 |
| Osteoarthritis | 0.3 | 0.3 | |
| Osteoporosis | 0.6 | 0.3 | 1 |
| Parkinson's Disease | 1.1 | 0.6 | 0.83 |
| Polycystic ovary syndrome | 0.3 | 0.6 | -1 |
| Postural orthostatic tachycardia syndrome | 0.3 | -0.3 | |
| Premenstrual dysphoric disorder | 0.3 | 0.3 | |
| Psoriasis | 0.8 | 0.6 | 0.33 |
| rheumatoid arthritis (RA),Spondyloarthritis (SpA) | 0.8 | 0.8 | 0 |
| Rosacea | 0.6 | 0.6 | |
| Schizophrenia | 0.5 | 0.8 | -0.6 |
| Sjögren syndrome | 0.3 | 0.3 | 0 |
| Sleep Apnea | 0.3 | 0.3 | |
| Small Intestinal Bacterial Overgrowth (SIBO) | 0.5 | 0.5 | |
| Stress / posttraumatic stress disorder | 0.8 | 0.6 | 0.33 |
| Systemic Lupus Erythematosus | 0.6 | 0.6 | 0 |
| Tic Disorder | 0.3 | -0.3 | |
| Tourette syndrome | 0.3 | 0.3 | |
| Type 1 Diabetes | 0.6 | 0.3 | 1 |
| Type 2 Diabetes | 1.8 | 1.6 | 0.13 |
| Ulcerative colitis | 1 | 0.6 | 0.67 |
| Unhealthy Ageing | 0.6 | -0.6 |
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Explanations/Info/Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations. Please report any to us for correction.
Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.